Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease.
Autor: | Bymaster, Frank P., Whitesitt, Celia A., Shannon, Harlan E., DeLapp, Neil, Ward, John S., Calligaro, David O., Shipley, Lisa A., Buelke-Sam, Judith L., Bodick, Neil C., Farde, Lars, Sheardown, Malcolm J., Olesen, Preben H., Hansen, Kristian T., Suzdak, Peter D., Swedberg, Michael D.B., Sauerberg, Per, Mitch, Charles H. |
---|---|
Zdroj: | Drug Development Research; Feb1997, Vol. 40 Issue 2, p158-170, 13p |
Databáze: | Complementary Index |
Externí odkaz: |